
Tardive Dyskinesia and Drug Therapy in Geriatric Patients
George E. Crane, MD;
Ronald A. Smeets, MD
Arch Gen Psychiatry. 1974;30(3):341-343.
Abstract
The main objective of this paper was to relate tardive dyskinesia to the total intake of neuroleptics.
The data were based on a selected sample of geriatric patients, on accurate and complete information on chemotherapy, and on three neurological examinations.
A 7-point rating scale was used to distinguish drug-induced from spurious motor abnormalities. Two statistical approaches demonstrated that the risk of oral dyskinesia increases with the exposure to neuroleptics.
Author Affiliations
Baltimore
From Spring Grove State Hospital, Baltimore.
Footnotes
Accepted for publication Sept 28, 1973.
Reprint requests to Spring Grove State Hospital, Department of Mental Hygiene, Baltimore, MD 21228 (Dr. Crane).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Duration of Neuroleptic Treatment and Prevalence of Tardive Dyskinesia in Late Life
Sweet et al.
Arch Gen Psychiatry 1995;52:478-486.
ABSTRACT
Tardive Dyskinesia in the Aged: Duration of Treatment Relationships
Toenniessen et al.
Arch Gen Psychiatry 1985;42:278-284.
ABSTRACT
Tardive Dyskinesia in Psychiatric Outpatients: A Study of Prevalence and Association With Demographic, Clinical, and Drug History Variables
Mukherjee et al.
Arch Gen Psychiatry 1982;39:466-469.
ABSTRACT
Tardive Dyskinesia: Prevalence and Risk Factors, 1959 to 1979
Kane and Smith
Arch Gen Psychiatry 1982;39:473-481.
ABSTRACT
The Assessment of Tardive Dyskinesia
Gardos et al.
Arch Gen Psychiatry 1977;34:1206-1212.
ABSTRACT
|